Obuhangire bwa Denali Therapeutics (DNLI) bwa Sikaati
Denali Therapeutics
Ekigero ky'omukisa$20.40Yahindurirwe 25 KMW 2026 19:59 UTC
Change-0.34%
AI forecast: DNLI
AI ebandika ekiruho ky'obusobozi bw'omubere gw'ekiseera ekiddako, ekigero ky'omubere gw'ebirungi, n'ekigero ky'omubere gw'omwezi. Okuhinduka kuhakirizwa hakurikira obusobozi bwa nyuma. Bino ni obuhangire bw'obusobozi, si obuhangire bw'okuhanga.
Ebiharwa by'omwaka guhera mu myezi 6 eyita
Premium erikahyora ebyifujiraho by'AI eby'omutengo mu nsi y'omunzi omu, wiiki emu n'omwaka omu ku kizigirwa kino n'ebirala byonna.
Unlock Premium🔒 Ekihugho ky'obuhangire bw'obusobozi
Ekihugho ky'obuhangire bw'obusobozi — buli kihuugho ky'omubere gya nyuma hafi n'obusobozi bwa nyakuri — ni ekigero cya Premium.
Unlock PremiumEbikwata ku Kitongole Kino
Denali Therapeutics is a biotechnological company specializing in the opening and developing methods of treating patients with neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease, BAS and others.
